Dysregulated IL-7/IL-7R signaling and numerous increased risk association with IL-7R polymorphisms have been observed in patients suffering from IMID (e.g. multiple sclerosis, type 1 diabetes, rheumatoid arthritis, inflammatory bowel diseases). The gene discussed is IL7R; the disease is rheumatoid arthritis.